Back

Activation of fibroblast growth factor 21 by Canagliflozin reduces high-fat diet associated obesity-related cardiac injury: a translational study from bench to bedside

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Nutrition and heart disease Obesity ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Professor Ping-Yen Liu

National Cheng Kung University Hospital, Tainan (Taiwan)

8 More presentations in this session

Presentation thumbnail
Investigating the diverse role of ultra-processed foods on cardiometabolic multimorbidity: Highlights from the ATTICA prospective study (2002-2022)
Miss E. Damigou (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Cardioprotective potential of oleuropein, hydroxytyrosol, oleocanthal and their combination: unravelling complementary effects on acute myocardial infarction and metabolic syndrome.
Professor I. Andreadou (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Influence of chronic dietary nitrate on downstream atherogenic metabolites and the enteral microbiome
Doctor D. Messiha (Essen, DE)
Abstract Slides Video
Presentation thumbnail
Efficacy of diet with low glycemic index on coronary artery disease
Doctor J. Uzokov (Tashkent, UZ)
Abstract Slides Video
Presentation thumbnail
Mediterranean-type diet trajectories and 20-year cardiovascular disease incidence: the ATTICA study (2002-2022)
Miss E. Damigou (Athens, GR)
Abstract Slides Video

Access the full session

Session thumbnail
Nutrition and heart disease

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Effects of sodium-glucose contrasporter-2 inhibitors and glucagon-like peptide-1 receptor agonists on arterial stiffness, coronary flow reserve and liver steatosis in diabetes
thumbnail
Congress Presentation
The role of cardiac fibroblast growth factor receptor 1/beta klotho (FGFR1/KLB) signalling cascade in diabetic heart failure
thumbnail
Congress Presentation
Sodium-glucose co-transporter-2 inhibitors : a potential cardioprotective agent?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources